|
1
|
Barzon L, Sonino N, Fallo F, Palu G and
Boscaro M: Prevalence and natural history of adrenal
incidentalomas. Eur J Endocrinol. 149:273–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song JH, Chaudhry FS and Mayo-Smith WW:
The incidental adrenal mass on CT: Prevalence of adrenal disease in
1,049 consecutive adrenal masses in patients with no known
malignancy. AJR Am J Roentgenol. 190:1163–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fassnacht M, Arlt W, Bancos I, Dralle H,
Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S and
Dekkers OM: Management of adrenal incidentalomas: European society
of endocrinology clinical practice guideline in collaboration with
the european network for the study of adrenal tumors. Eur J
Endocrinol. 175:G1–G34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andersen MB, Bodtger U, Andersen IR,
Thorup KS, Ganeshan B and Rasmussen F: Metastases or benign adrenal
lesions in patients with histopathological verification of lung
cancer: Can CT texture analysis distinguish? Eur J Radiol.
138:1096642021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Terzolo M, Stigliano A, Chiodini I, Loli
P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, et
al: AME position statement on adrenal incidentaloma. Eur J
Endocrinol. 164:851–870. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gaujoux S and Mihai R; Joint working group
of ESES and ENSAT, : European society of endocrine surgeons (ESES)
and european network for the study of adrenal tumours (ENSAT)
recommendations for the surgical management of adrenocortical
carcinoma. Br J Surg. 104:358–376. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Young WF Jr: Clinical practice. The
incidentally discovered adrenal mass. N Engl J Med. 356:601–610.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ilias I, Sahdev A, Reznek RH, Grossman AB
and Pacak K: The optimal imaging of adrenal tumours: A comparison
of different methods. Endocr Relat Cancer. 14:587–599. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zeiger MA, Siegelman SS and Hamrahian AH:
Medical and surgical evaluation and treatment of adrenal
incidentalomas. J Clin Endocrinol Metab. 96:2004–2015. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mayo-Smith WW, Song JH, Boland GL, Francis
IR, Israel GM, Mazzaglia PJ, Berland LL and Pandharipande PV:
Management of incidental adrenal masses: A white paper of the ACR
incidental findings committee. J Am Coll Radiol. 14:1038–1044.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bednarczuk T, Bolanowski M, Sworczak K,
Górnicka B, Cieszanowski A, Otto M, Ambroziak U, Pachucki J,
Kubicka E, Babińska A, et al: Adrenal incidentaloma in
adults-management recommendations by the Polish society of
endocrinology. Endokrynol Pol. 67:234–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pandharipande PV, Herts BR, Gore RM,
Mayo-Smith WW, Harvey HB, Megibow AJ and Berland LL: Rethinking
normal: Benefits and risks of not reporting harmless incidental
findings. J Am Coll Radiol. 13:764–767. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujiyoshi F, Nakajo M, Fukukura Y and
Tsuchimochi S: Characterization of adrenal tumors by chemical shift
fast low-angle shot MR imaging: Comparison of four methods of
quantitative evaluation. AJR Am J Roentgenol. 180:1649–1657. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guerin C, Pattou F, Brunaud L, Lifante JC,
Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer
C, et al: Performance of 18F-FDG PET/CT in the characterization of
adrenal masses in noncancer patients: A prospective study. J Clin
Endocrinol Metab. 102:2465–2472. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caoili EM, Korobkin M, Francis IR, Cohan
RH, Platt JF, Dunnick NR and Raghupathi KI: Adrenal masses:
Characterization with combined unenhanced and delayed enhanced CT.
Radiology. 222:629–633. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haider MA, Ghai S, Jhaveri K and Lockwood
G: Chemical shift MR imaging of hyperattenuating (>10 HU)
adrenal masses: does it still have a role? Radiology. 231:711–716.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Koo HJ, Choi HJ, Kim HJ, Kim SO and Cho
KS: The value of 15-minute delayed contrast-enhanced CT to
differentiate hyperattenuating adrenal masses compared with
chemical shift MR imaging. Eur Radiol. 24:1410–1420. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akkus G, Guney IB, Ok F, Evran M, Izol V,
Erdogan S, Bayazit Y, Sert M and Tetiker T: Diagnostic efficacy of
18F-FDG PET/CT in patients with adrenal incidentaloma. Endocr
Connect. 8:838–845. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kassirer JP: Our stubborn quest for
diagnostic certainty. A cause of excessive testing. N Engl J Med.
320:1489–1491. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lambin P, Leijenaar RTH, Deist TM,
Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R,
Even AJG, Jochems A, et al: Radiomics: the bridge between medical
imaging and personalized medicine. Nat Rev Clin Oncol. 14:749–762.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang C, Jiang Z, Cheng T, Zhou R, Wang G,
Jing D, Bo L, Huang P, Wang J, Zhang D, et al: Radiomics for
predicting response of neoadjuvant chemotherapy in nasopharyngeal
carcinoma: A systematic review and meta-analysis. Front Oncol.
12:8931032022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gillies RJ, Kinahan PE and Hricak H:
Radiomics: Images are more than pictures, they are data. Radiology.
278:563–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Z, Yang J, Ho A, Jiang W, Logan J,
Wang X, Brown PD, McGovern SL, Guha-Thakurta N, Ferguson SD, et al:
Correction to: A predictive model for distinguishing radiation
necrosis from tumour progression after gamma knife radiosurgery
based on radiomic features from MR images. Eur Radiol.
28:3570–3571. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishino M, Jagannathan JP, Ramaiya NH and
Van den Abbeele AD: Revised RECIST guideline version 1.1: What
oncologists want to know and what radiologists need to know. AJR Am
J Roentgenol. 195:281–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee HY, Oh YL and Park SY:
Hyperattenuating adrenal lesions in lung cancer: Biphasic CT with
unenhanced and 1-min enhanced images reliably predicts benign
lesions. Eur Radiol. 31:5948–5958. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Guan X, Xu B, Zeng F, Chen C, Yin
HL, Yi X, Peng Y and Chen BT: Computed tomography-based machine
learning differentiates adrenal pheochromocytoma from lipid-poor
adenoma. Front Endocrinol (Lausanne). 13:8334132022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang GM, Shi B, Sun H, Jin ZY and Xue HD:
Differentiating pheochromocytoma from lipid-poor adrenocortical
adenoma by CT texture analysis: feasibility study. Abdom Radiol
(NY). 42:2305–2313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ettinghausen SE and Burt ME: Prospective
evaluation of unilateral adrenal masses in patients with operable
non-small-cell lung cancer. J Clin Oncol. 9:1462–1466. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yi X, Guan X, Zhang Y, Liu L, Long X, Yin
H, Wang Z, Li X, Liao W, Chen BT and Zee C: Radiomics improves
efficiency for differentiating subclinical pheochromocytoma from
lipid-poor adenoma: A predictive, preventive and personalized
medical approach in adrenal incidentalomas. EPMA J. 9:421–429.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He K, Zhang ZT, Wang ZH, Wang Y, Wang YX,
Zhang HZ, Dong YF and Xiao XL: A clinical-radiomic nomogram based
on unenhanced computed tomography for predicting the risk of
aldosterone-producing adenoma. Front Oncol. 11:6348792021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ho LM, Samei E, Mazurowski MA, Zheng Y,
Allen BC, Nelson RC and Marin D: Can texture analysis be used to
distinguish benign from malignant adrenal nodules on unenhanced CT,
contrast-enhanced CT, or in-phase and opposed-phase MRI? AJR Am J
Roentgenol. 212:554–561. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tu W, Verma R, Krishna S, McInnes MDF,
Flood TA and Schieda N: Can adrenal adenomas be differentiated from
adrenal metastases at single-phase contrast-enhanced CT? AJR Am J
Roentgenol. 211:1044–1050. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Groot P and Munden RF: Lung cancer
epidemiology, risk factors, and prevention. Radiol Clin North Am.
50:863–876. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moawad AW, Ahmed A, Fuentes DT, Hazle JD,
Habra MA and Elsayes KM: Machine learning-based texture analysis
for differentiation of radiologically indeterminate small adrenal
tumors on adrenal protocol CT scans. Abdom Radiol (NY).
46:4853–4863. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
You X, Sun X, Yang C and Fang Y: CT
diagnosis and differentiation of benign and malignant varieties of
solitary fibrous tumor of the pleura. Medicine (Baltimore).
96:e90582017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ganeshan B, Goh V, Mandeville HC, Ng QS,
Hoskin PJ and Miles KA: Non-small cell lung cancer: Histopathologic
correlates for texture parameters at CT. Radiology. 266:326–336.
2013. View Article : Google Scholar : PubMed/NCBI
|
